Crescita Therapeutics
(OTC) CRRTF
Crescita Therapeutics Financials at a Glance
Market Cap
$10.05M
Revenue (TTM)
$22.07M
Net Income (TTM)
$457.00K
EPS (TTM)
$0.02
P/E Ratio
27.98
Dividend
$0.00
Beta (Volatility)
-0.58 (Low)
Dividend
$0.00
Beta (Volatility)
-0.58 (Low)
Price
$0.54
Volume
3,500
Open
$0.54
Price
$0.54
Volume
3,500
Open
$0.54
Previous Close
$0.54
Daily Range
$0.54 - $0.54
52-Week Range
$0.02 - $0.55
Dividend
$0.00
Beta (Volatility)
-0.58 (Low)
Price
$0.54
Volume
3,500
Open
$0.54
Previous Close
$0.54
Daily Range
$0.54 - $0.54
52-Week Range
$0.02 - $0.55
CRRTF News
CRRTF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Crescita Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
80
CEO
Serge Verreault, MBA
Website
www.crescitatherapeutics.comHeadquarters
Laval, QC H7V 0A3, CA
CRRTF Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
-4%
Net Income Margin
2%
Return on Equity
3%
Return on Capital
-6%
Return on Assets
2%
Earnings Yield
3.57%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.05M
Shares Outstanding
18.61M
Volume
3.50K
Short Interest
0.00%
Avg. Volume
1.63K
Financials (TTM)
Gross Profit
$9.61M
Operating Income
$3.21M
EBITDA
$1.33M
Operating Cash Flow
$2.73M
Capital Expenditure
$1.19M
Free Cash Flow
$1.54M
Cash & ST Invst.
$9.27M
Total Debt
$834.00K
Crescita Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.39M
+50.1%
Gross Profit
$2.85M
+45.1%
Gross Margin
52.94%
N/A
Market Cap
$10.05M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$753.00K
+172.7%
EBITDA
$1.15M
+261.8%
Quarterly Fundamentals
Net Cash
$7.82M
+4.2%
Accounts Receivable
$1.91M
+50.2%
Inventory
$5.36M
-12.5%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$484.00K
+6.8%
Return on Assets
2.13%
N/A
Return on Invested Capital
-5.56%
N/A
Free Cash Flow
$1.13M
+376.2%
Operating Cash Flow
$1.17M
+176.7%